Impact of Antithrombotic Therapy on Survival Outcomes in Advanced Melanoma Patients Receiving Targeted Therapy: Insights from the Prospective Multicenter ADOReg Registry

Background: BRAF/MEK inhibitors (BRAFi/MEKi) improve clinical outcomes in patients with BRAF-mutated metastatic melanoma.However, the treatment is associated with a risk of cardiotoxicity, potentially leading to decline in left ventricular ejection fraction (LVEF).This study aimed to evaluate the incidence, timeline, risk

Authors

Institutions

Publication Details

Journal
EJC Skin Cancer
Published
2025-01-01
DOI
https://doi.org/10.1016/j.ejcskn.2025.100619
Primary Topic
Cutaneous Melanoma Detection and Management
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Impact of Antithrombotic Therapy on Survival Outcomes in Advanced Melanoma Patients Receiving Targeted Therapy: Insights from the Prospective Multicenter ADOReg Registry

Patrick Terheyden, Carola Berking, Jochen Sven Utikal, Darren J. Smit et al.
EJC Skin Cancer
Cutaneous Melanoma Detection and Management
article

Impact of Antithrombotic Therapy on Survival Outcomes in Advanced Melanoma Patients Receiving Targeted Therapy: Insights from the Prospective Multicenter ADOReg Registry

Patrick Terheyden, Carola Berking, Jochen Sven Utikal, Darren J. Smit, Rudolf Alexander Herbst, Christoffer Gebhardt, Traci Zell, Michael Weichenthal, Claudia Pföhler, Sebastian Haferkamp, Julian Kött, Dirk Schadendorf, Friedegund Meier, Glenn Geidel, Fabian Ziller, Benjamin Deitert, Peter J. Mohr, Sarah N. Belz, Selma Ugurel, Alexander T. Bauer, Alessandra Rünger, R. Gutzmer, Nick Zimmermann, Chiara L. Blomen, Ulrike Leiter, Stefan W. Schneider, I. Heidrich, Martin Kaatz, Imke von Wasielewski, Atefeh Abedini, Jens Ulrich
article en

Abstract

Background: BRAF/MEK inhibitors (BRAFi/MEKi) improve clinical outcomes in patients with BRAF-mutated metastatic melanoma.However, the treatment is associated with a risk of cardiotoxicity, potentially leading to decline in left ventricular ejection fraction (LVEF).This study aimed to evaluate the incidence, timeline, risk

EJC Skin CancerVol. 3
Universität Hamburg (DE), German Cancer Research Center (DE), Heidelberg University (DE), University Medical Center Freiburg (DE), Dorothea Dix Hospital (US), University Hospital Heidelberg (DE), University Hospital Regensburg (DE), Medizinische Hochschule Hannover (DE), Universitätsklinikum Erlangen (DE), SRH Wald-Klinikum Gera (DE), University Medical Center Hamburg-Eppendorf (DE), National Center for Tumor Diseases (DE), University Hospital Schleswig-Holstein (DE), Essen University Hospital (DE), University Cancer Center Hamburg (DE), Elbe Kliniken Stade-Buxtehude (DE), Helios Klinikum Erfurt (DE), Comprehensive Cancer Center Erlangen (DE), University Medical Centre Mannheim (DE), University Hospital Carl Gustav Carus (DE), Klinikum Chemnitz (DE), Johannes Wesling Klinikum Minden (DE), University of Duisburg-Essen (DE), University of Tübingen (DE), Saarland University (DE), University of Lübeck (DE)
Openalex Percentile: Top 90%
Cutaneous Melanoma Detection and Management
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.